
    
      This study is to evaluate the efficacy (HbA1c change from baseline) and safety of ASP1941 in
      combination with metformin in subjects with type 2 diabetes mellitus (T2DM) who have
      inadequate glycemic control with metformin alone. The effects of ASP1941 are compared with
      those of placebo.
    
  